Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A Safety Study of TDS-943
2004-001586-18Phase 3Completed
- Sponsor
- Pfizer
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of TDS-943 in arthralgia, myalgia, arthritis and 1 more (5 arms), sponsored by Pfizer. Primary endpoint: Study discontinuation rate. Started Feb 2005; status: completed.
02
Drugs
TDS-943
03
Conditions
arthralgiamyalgiaarthritismyositis
Beyond the preview
Go deeper on 2004-001586-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001586-18.